|
The World Health Organization predicted
that in 2010, cancer will become the world’s
leading cause of death, replacing cardiovascular diseases. One in two men and women
experience cancer in their lifetimes; in Europe each year, 3.2 million are diagnosed with
cancer, and 1.7 million die.
Doctors mainly treat cancer with surgery, chemotherapy, radiation, or some combination,
depending on the cancer type and stage. But when large tumors lie next to critical
organs, interventional oncology is effective and is gaining favor.
Interventional oncology uses precisely targeted, minimally or non-invasive
procedures under real-time image guidance to destroy primary tumors
and metastases. It can be used for curative or for palliative treatment
or as adjuvant or neoadjuvant therapy. The field has grown rapidly
and has reached several milestones in the past two years, thanks
to advancing technology and the development of multimodal
combination therapies and fusion imaging.
Interventional oncology has increasingly adopted proven rotational
3D angiography performed with digital flat panels.
Now, with the integration of multimodality imaging on the workstation,
interventionalists can employ new functionalities to help them tackle
even the most complex lesions. Advanced tools from GE Healthcare
include rotational imaging on Innova* interventional imaging systems
and the Advantage Workstation (AW) VolumeShare*.
*Innova and Advantage VolumeShare are trademarks of the General Electric Company.
| 
